Project: dissection
1051 significantly associated models · 164 unique genes
# | chr | p0 | p1 | # assoc genes | # joint models | best TWAS P | best SNP P | cond SNP P | % var exp | joint genes |
---|---|---|---|---|---|---|---|---|---|---|
1 | 1 | 169577644 | 171448580 | 6 | 1 | 2.4e-07 | 1.5e-07 | 1.0000 | 100 | Sox6 |
2 | 1 | 254740406 | 257259017 | 4 | 1 | 7.0e-08 | 4.3e-08 | 0.0909 | 90 | Casp7 |
3 | 1 | 258394596 | 260518987 | 12 | 5 | 3.9e-12 | 7.8e-14 | NaN | NaN | Rab11fip2 Fam204a Prlhr Cacul1 Nanos1 |
4 | 3 | 105151820 | 106550924 | 1 | 1 | 2.8e-08 | 1.1e-05 | 1.0000 | 100 | Ivd |
5 | 5 | 109125119 | 110596972 | 3 | 1 | 5.2e-08 | 4.1e-06 | 0.3266 | 95 | NA |
6 | 7 | 110098486 | 121146934 | 104 | 10 | 1.7e-13 | 8.0e-13 | 1.0000 | 100 | Ccdc134 Septin3 Nup50 Josd1 Xpnpep3 Rrp7a Serhl2 Cyp2d4 Sult4a1 NA |
7 | 9 | 106993481 | 108434469 | 2 | 1 | 1.2e-08 | 7.8e-10 | 0.0049 | 79 | Arhgap28 |
8 | 12 | 27006 | 6860177 | 28 | 7 | 1.0e-09 | 1.2e-08 | NaN | NaN | Fry Stard13 Arhgef18 AABR07035218.1 Katnal1 B3glct Zfp958 |
9 | 16 | 19065621 | 19932386 | 1 | 1 | 4.7e-09 | 1.3e-03 | 0.6919 | 98 | NA |
10 | 19 | 36759451 | 38410018 | 3 | 1 | 3.6e-08 | 1.1e-08 | 0.0658 | 90 | Pmfbp1 |
p0: physical position of the start of the locus. p1: physical position of the end of the locus. # joint models: number of models selected by step-wise conditional analysis.
chisq ratio: Average Chi2 statistic for the selected genes in the secondary trait, divided by the average statistic for all genes in the secondary trait. # genes+: Shared significant genes at Bonferroni correction. # genes++: Shared significant genes at transcriptome-wide significance. % genes++: Number of [++] genes as a percentage of primary trait’s total joint genes. corr: Correlation of effect sizes across the [+] genes.
tissue | modality | # hits | % hits/tests | avg chisq |
---|---|---|---|---|
Adipose | alternative polyA | 17 | 0.80 | 3.0 |
Adipose | alternative TSS | 10 | 0.62 | 3.2 |
Adipose | gene expression | 50 | 0.60 | 2.7 |
Adipose | isoform ratio | 16 | 0.57 | 2.8 |
Adipose | intron excision ratio | 16 | 0.55 | 2.8 |
Adipose | mRNA stability | 24 | 0.70 | 2.7 |
BLA | alternative polyA | 8 | 0.67 | 2.9 |
BLA | alternative TSS | 9 | 1.07 | 3.0 |
BLA | gene expression | 43 | 0.71 | 2.8 |
BLA | isoform ratio | 14 | 0.80 | 3.0 |
BLA | intron excision ratio | 28 | 0.94 | 3.0 |
BLA | mRNA stability | 18 | 0.89 | 3.1 |
Brain | alternative polyA | 11 | 0.55 | 2.8 |
Brain | alternative TSS | 17 | 0.99 | 2.9 |
Brain | gene expression | 53 | 0.59 | 2.8 |
Brain | isoform ratio | 22 | 0.70 | 2.8 |
Brain | intron excision ratio | 43 | 0.80 | 3.0 |
Brain | mRNA stability | 34 | 0.78 | 2.8 |
Eye | alternative polyA | 0 | 0.00 | 2.7 |
Eye | alternative TSS | 0 | 0.00 | 2.9 |
Eye | gene expression | 9 | 0.80 | 3.0 |
Eye | isoform ratio | 0 | 0.00 | 2.7 |
Eye | intron excision ratio | 6 | 0.98 | 3.2 |
Eye | mRNA stability | 2 | 0.86 | 3.0 |
IL | alternative polyA | 4 | 0.66 | 3.3 |
IL | alternative TSS | 0 | 0.00 | 2.6 |
IL | gene expression | 26 | 0.71 | 2.9 |
IL | isoform ratio | 5 | 0.63 | 3.2 |
IL | intron excision ratio | 7 | 0.73 | 2.9 |
IL | mRNA stability | 8 | 0.72 | 2.7 |
LHb | alternative polyA | 1 | 0.17 | 2.6 |
LHb | alternative TSS | 0 | 0.00 | 2.3 |
LHb | gene expression | 27 | 0.84 | 3.0 |
LHb | isoform ratio | 3 | 0.40 | 3.0 |
LHb | intron excision ratio | 10 | 0.97 | 3.0 |
LHb | mRNA stability | 7 | 0.68 | 2.9 |
Liver | alternative polyA | 8 | 0.53 | 3.0 |
Liver | alternative TSS | 0 | 0.00 | 2.6 |
Liver | gene expression | 31 | 0.43 | 2.6 |
Liver | isoform ratio | 12 | 0.50 | 2.9 |
Liver | intron excision ratio | 30 | 0.69 | 2.8 |
Liver | mRNA stability | 14 | 0.57 | 2.8 |
NAcc | alternative polyA | 1 | 0.19 | 3.3 |
NAcc | alternative TSS | 2 | 0.58 | 2.8 |
NAcc | gene expression | 28 | 0.85 | 3.0 |
NAcc | isoform ratio | 5 | 0.67 | 3.1 |
NAcc | intron excision ratio | 8 | 0.84 | 2.9 |
NAcc | mRNA stability | 12 | 1.11 | 3.2 |
NAcc2 | alternative polyA | 10 | 0.90 | 3.1 |
NAcc2 | alternative TSS | 8 | 1.09 | 3.2 |
NAcc2 | gene expression | 49 | 0.92 | 3.0 |
NAcc2 | isoform ratio | 10 | 0.65 | 2.8 |
NAcc2 | intron excision ratio | 21 | 0.79 | 3.0 |
NAcc2 | mRNA stability | 12 | 0.67 | 2.9 |
OFC | alternative polyA | 6 | 1.03 | 3.3 |
OFC | alternative TSS | 0 | 0.00 | 2.3 |
OFC | gene expression | 25 | 0.67 | 3.0 |
OFC | isoform ratio | 7 | 0.86 | 3.1 |
OFC | intron excision ratio | 6 | 0.60 | 2.8 |
OFC | mRNA stability | 8 | 0.74 | 2.9 |
PL | alternative polyA | 5 | 0.83 | 3.2 |
PL | alternative TSS | 0 | 0.00 | 2.2 |
PL | gene expression | 32 | 0.86 | 2.9 |
PL | isoform ratio | 9 | 1.03 | 3.1 |
PL | intron excision ratio | 7 | 0.67 | 2.9 |
PL | mRNA stability | 6 | 0.52 | 2.8 |
PL2 | alternative polyA | 13 | 1.04 | 3.0 |
PL2 | alternative TSS | 13 | 1.38 | 3.3 |
PL2 | gene expression | 43 | 0.67 | 2.8 |
PL2 | isoform ratio | 16 | 0.87 | 3.0 |
PL2 | intron excision ratio | 25 | 0.79 | 3.0 |
PL2 | mRNA stability | 21 | 0.86 | 2.9 |
avg chisq: Average Chi2 (squared Z-score) across all models in this panel for this trait.